{"transactions":[{"id":820522,"issuer":{"id":7194,"kind":"organization","name":"SCYNEXIS INC","symbol":"SCYX"},"owners":[{"id":54378,"kind":"person","name":"Angulo Gonzalez David","position":1,"cik":"0001644071","reported_name":"Angulo Gonzalez David","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Warrant to Purchase Common Stock","published_at":"2026-04-02T12:01:21.000Z","date":"2026-04-01","kind":"purchase","planned":false,"acquired":true,"shares":108695,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On March 30, 2026, the Issuer entered into a Securities Purchase Agreement with certain accredited investors, including the Reporting Person (the \"Purchase Agreement\"). Pursuant to the terms of the Purchase Agreement, the Issuer issued and sold to the Reporting Person in a private placement, which closed on April 1, 2026, 108,695 shares of the Issuer's common stock (the \"Shares\") and accompanying warrants to purchase up to 108,695 shares of common stock of the Issuer (the \"Common Warrants\"). The combined purchase price for each Share and accompanying Common Warrant was $0.92."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The Common Warrants will be exercisable beginning on the effective date of the stockholder approval relating to the proposed increase in the Issuer's authorized shares of common stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The Common Warrants will expire on the earlier of (i) the fifth (5th) anniversary of its original issue date and (ii) the thirtieth (30th) day after the Issuer publicly releases topline data at Week 48 from the Issuer's Phase 2 proof-ofconcept\nclinical study evaluating SCY-770 in patients with autosomal dominant polycystic kidney disease."}],"balance_after":108695,"derivative":{"exercise_price":1.2,"underlying":"Common Stock","underlying_shares":108695},"source":{"system":"sec-edgar","filing":"0001644071-26-000002","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1178253/000164407126000002/ownership.xml","form_type":"4"}},{"id":820521,"issuer":{"id":7194,"kind":"organization","name":"SCYNEXIS INC","symbol":"SCYX"},"owners":[{"id":54378,"kind":"person","name":"Angulo Gonzalez David","position":1,"cik":"0001644071","reported_name":"Angulo Gonzalez David","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-04-02T12:01:21.000Z","date":"2026-04-01","kind":"purchase","planned":false,"acquired":true,"shares":108695,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On March 30, 2026, the Issuer entered into a Securities Purchase Agreement with certain accredited investors, including the Reporting Person (the \"Purchase Agreement\"). Pursuant to the terms of the Purchase Agreement, the Issuer issued and sold to the Reporting Person in a private placement, which closed on April 1, 2026, 108,695 shares of the Issuer's common stock (the \"Shares\") and accompanying warrants to purchase up to 108,695 shares of common stock of the Issuer (the \"Common Warrants\"). The combined purchase price for each Share and accompanying Common Warrant was $0.92."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 4,000 shares of common stock acquired under the 2014 Employee Stock Purchase Plan of the Issuer on March 5, 2026."}],"balance_after":1357126,"source":{"system":"sec-edgar","filing":"0001644071-26-000002","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1178253/000164407126000002/ownership.xml","form_type":"4"}},{"id":925595,"issuer":{"id":7194,"kind":"organization","name":"SCYNEXIS INC","symbol":"SCYX"},"owners":[{"id":54378,"kind":"person","name":"Angulo Gonzalez David","position":1,"cik":"0001644071","reported_name":"Angulo Gonzalez David","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-02-02T21:01:08.000Z","date":"2026-01-29","kind":"grant","planned":false,"acquired":true,"shares":391333,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units that vest one third per year over three years as measured from February 28, 2026."}],"balance_after":1244431,"source":{"system":"sec-edgar","filing":"0001178253-26-000003","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1178253/000117825326000003/ownership.xml","form_type":"4"}},{"id":1015389,"issuer":{"id":7194,"kind":"organization","name":"SCYNEXIS INC","symbol":"SCYX"},"owners":[{"id":54378,"kind":"person","name":"Angulo Gonzalez David","position":1,"cik":"0001644071","reported_name":"Angulo Gonzalez David","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-10-21T12:00:08.000Z","date":"2025-10-17","kind":"grant","planned":false,"acquired":true,"shares":32500,"price":0.76,"value":24700.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 4,000 shares of common stock acquired under the 2014 Employee Stock Purchase Plan on September 5, 2025."}],"balance_after":853098,"source":{"system":"sec-edgar","filing":"0001178253-25-000007","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1178253/000117825325000007/ownership.xml","form_type":"4"}},{"id":1174248,"issuer":{"id":7194,"kind":"organization","name":"SCYNEXIS INC","symbol":"SCYX"},"owners":[{"id":54378,"kind":"person","name":"Angulo Gonzalez David","position":1,"cik":"0001644071","reported_name":"Angulo Gonzalez David","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-04-10T12:02:09.000Z","date":"2025-04-09","kind":"grant","planned":false,"acquired":true,"shares":23000,"price":0.84,"value":19320.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.8384 to $0.85, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range."}],"balance_after":816598,"source":{"system":"sec-edgar","filing":"0000950170-25-052675","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1178253/000095017025052675/ownership.xml","form_type":"4"}},{"id":1195950,"issuer":{"id":7194,"kind":"organization","name":"SCYNEXIS INC","symbol":"SCYX"},"owners":[{"id":54378,"kind":"person","name":"Angulo Gonzalez David","position":1,"cik":"0001644071","reported_name":"Angulo Gonzalez David","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-03-20T23:39:22.000Z","date":"2025-03-20","kind":"grant","planned":false,"acquired":true,"shares":13800,"price":1.05,"value":14490.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.05 to $1.06, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range."}],"balance_after":793598,"source":{"system":"sec-edgar","filing":"0000950170-25-042838","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1178253/000095017025042838/ownership.xml","form_type":"4"}},{"id":1195949,"issuer":{"id":7194,"kind":"organization","name":"SCYNEXIS INC","symbol":"SCYX"},"owners":[{"id":54378,"kind":"person","name":"Angulo Gonzalez David","position":1,"cik":"0001644071","reported_name":"Angulo Gonzalez David","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-03-20T23:39:22.000Z","date":"2025-03-19","kind":"grant","planned":false,"acquired":true,"shares":5000,"price":1.07,"value":5350.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 4,000 shares of common stock acquired under the 2014 Employee Stock Purchase Plan on March 5, 2025."}],"balance_after":779798,"source":{"system":"sec-edgar","filing":"0000950170-25-042838","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1178253/000095017025042838/ownership.xml","form_type":"4"}},{"id":1294643,"issuer":{"id":7194,"kind":"organization","name":"SCYNEXIS INC","symbol":"SCYX"},"owners":[{"id":54378,"kind":"person","name":"Angulo Gonzalez David","position":1,"cik":"0001644071","reported_name":"Angulo Gonzalez David","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2025-01-27T21:01:17.000Z","date":"2025-01-23","kind":"grant","planned":false,"acquired":true,"shares":394391,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"1/48th of the shares subject to the option vest monthly for 48 months as measured from January 23, 2025."}],"balance_after":394391,"derivative":{"exercise_price":1.08,"expiration_date":"2035-01-22","underlying":"Common Stock","underlying_shares":394391},"source":{"system":"sec-edgar","filing":"0000950170-25-009170","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1178253/000095017025009170/ownership.xml","form_type":"4"}},{"id":1294642,"issuer":{"id":7194,"kind":"organization","name":"SCYNEXIS INC","symbol":"SCYX"},"owners":[{"id":54378,"kind":"person","name":"Angulo Gonzalez David","position":1,"cik":"0001644071","reported_name":"Angulo Gonzalez David","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-01-27T21:01:17.000Z","date":"2025-01-23","kind":"grant","planned":false,"acquired":true,"shares":262927,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units that vest one third per year over three years as measured from February 28, 2025."}],"balance_after":770798,"source":{"system":"sec-edgar","filing":"0000950170-25-009170","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1178253/000095017025009170/ownership.xml","form_type":"4"}},{"id":1406879,"issuer":{"id":7194,"kind":"organization","name":"SCYNEXIS INC","symbol":"SCYX"},"owners":[{"id":54378,"kind":"person","name":"Angulo Gonzalez David","position":1,"cik":"0001644071","reported_name":"Angulo Gonzalez David","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2024-09-16T12:00:27.000Z","date":"2024-09-12","kind":"purchase","planned":false,"acquired":true,"shares":20000,"price":1.37,"value":27400.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.35 to $1.40, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 8,000 shares of common stock acquired under the 2014 Employee Stock Purchase Plan on March 5, 2024 (4,000 shares) and September 5, 2024 (4,000 shares)."}],"balance_after":507871,"source":{"system":"sec-edgar","filing":"0000950170-24-106610","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1178253/000095017024106610/ownership.xml","form_type":"4"}},{"id":1666796,"issuer":{"id":7194,"kind":"organization","name":"SCYNEXIS INC","symbol":"SCYX"},"owners":[{"id":54378,"kind":"person","name":"Angulo Gonzalez David","position":1,"cik":"0001644071","reported_name":"Angulo Gonzalez David","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2024-01-30T21:03:13.000Z","date":"2024-01-26","kind":"grant","planned":false,"acquired":true,"shares":431030,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"1/48th of the shares subject to the option vest monthly for 48 months as measured from February 15, 2024."}],"balance_after":431030,"derivative":{"exercise_price":1.86,"expiration_date":"2034-01-25","underlying":"Common Stock","underlying_shares":431030},"source":{"system":"sec-edgar","filing":"0000950170-24-008808","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1178253/000095017024008808/ownership.xml","form_type":"4"}},{"id":1666795,"issuer":{"id":7194,"kind":"organization","name":"SCYNEXIS INC","symbol":"SCYX"},"owners":[{"id":54378,"kind":"person","name":"Angulo Gonzalez David","position":1,"cik":"0001644071","reported_name":"Angulo Gonzalez David","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2024-01-30T21:03:13.000Z","date":"2024-01-26","kind":"grant","planned":false,"acquired":true,"shares":290590,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units that vest one third per year over three years as measured from February 15, 2024."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 4,100 shares of common stock acquired under the 2014 Employee Stock Purchase Plan in March 2023 (100 shares) and September 2023 (4,000 shares)."}],"balance_after":479871,"source":{"system":"sec-edgar","filing":"0000950170-24-008808","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1178253/000095017024008808/ownership.xml","form_type":"4"}},{"id":2072955,"issuer":{"id":7194,"kind":"organization","name":"SCYNEXIS INC","symbol":"SCYX"},"owners":[{"id":54378,"kind":"person","name":"Angulo Gonzalez David","position":1,"cik":"0001644071","reported_name":"Angulo Gonzalez David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2023-01-03T21:01:29.000Z","date":"2023-01-01","kind":"grant","acquired":true,"shares":165000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"1/48th of the shares subject to the option vest monthly for 48 months as measured from the date of grant."}],"balance_after":165000,"derivative":{"exercise_price":1.56,"expiration_date":"2032-12-31","underlying":"Common Stock","underlying_shares":165000},"source":{"system":"sec-edgar","filing":"0001209191-23-000155","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1178253/000120919123000155/doc4.xml","form_type":"4"}},{"id":2072954,"issuer":{"id":7194,"kind":"organization","name":"SCYNEXIS INC","symbol":"SCYX"},"owners":[{"id":54378,"kind":"person","name":"Angulo Gonzalez David","position":1,"cik":"0001644071","reported_name":"Angulo Gonzalez David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2023-01-03T21:01:29.000Z","date":"2023-01-01","kind":"grant","acquired":true,"shares":110000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units that vest one third per year over three years on the anniversary of the date of grant."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 200 shares of common stock acquired under the 2014 Employee Stock Purchase Plan in March 2022 (100 shares) and September 2022 (100 shares)."}],"balance_after":185181,"source":{"system":"sec-edgar","filing":"0001209191-23-000155","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1178253/000120919123000155/doc4.xml","form_type":"4"}},{"id":2408690,"issuer":{"id":7194,"kind":"organization","name":"SCYNEXIS INC","symbol":"SCYX"},"owners":[{"id":54378,"kind":"person","name":"Angulo Gonzalez David","position":1,"cik":"0001644071","reported_name":"Angulo Gonzalez David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-02-08T21:11:09.000Z","date":"2022-02-04","kind":"grant","acquired":true,"shares":85000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"1/48th of the shares subject to the option vest monthly for 48 months as measured from the date of grant."}],"balance_after":85000,"derivative":{"exercise_price":4.6,"expiration_date":"2032-02-03","underlying":"Common Stock","underlying_shares":85000},"source":{"system":"sec-edgar","filing":"0001209191-22-007727","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1178253/000120919122007727/doc4.xml","form_type":"4"}},{"id":2408689,"issuer":{"id":7194,"kind":"organization","name":"SCYNEXIS INC","symbol":"SCYX"},"owners":[{"id":54378,"kind":"person","name":"Angulo Gonzalez David","position":1,"cik":"0001644071","reported_name":"Angulo Gonzalez David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2022-02-08T21:11:09.000Z","date":"2022-02-04","kind":"grant","acquired":true,"shares":51100,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units that vest 50% per year over two years on the anniversary of the date of grant."}],"balance_after":74981,"source":{"system":"sec-edgar","filing":"0001209191-22-007727","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1178253/000120919122007727/doc4.xml","form_type":"4"}},{"id":2886207,"issuer":{"id":7194,"kind":"organization","name":"SCYNEXIS INC","symbol":"SCYX"},"owners":[{"id":54378,"kind":"person","name":"Angulo Gonzalez David","position":1,"cik":"0001644071","reported_name":"Angulo Gonzalez David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-02-02T21:00:37.000Z","date":"2021-01-29","kind":"grant","acquired":true,"shares":65000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/48th of the shares subject to the option vest monthly for 48 months as measured from the date of grant."}],"balance_after":65000,"derivative":{"exercise_price":7.47,"expiration_date":"2031-01-28","underlying":"Common Stock","underlying_shares":65000},"source":{"system":"sec-edgar","filing":"0001209191-21-006715","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1178253/000120919121006715/doc4.xml","form_type":"4"}},{"id":2933300,"issuer":{"id":7194,"kind":"organization","name":"SCYNEXIS INC","symbol":"SCYX"},"owners":[{"id":54378,"kind":"person","name":"Angulo Gonzalez David","position":1,"cik":"0001644071","reported_name":"Angulo Gonzalez David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock Warrant","published_at":"2020-12-23T14:00:47.000Z","date":"2020-12-21","kind":"grant","acquired":true,"shares":800,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reflects the purchase on December 21, 2020 of 1,600 shares of the issuer's common stock, par value $0.001 per share, at a public offering price of $6.25 per share of common stock and accompanying warrants to purchase 0.50 of a share of common stock (Series 1 warrant) and 0.50 of a share of common stock (Series 2 warrant)."}],"balance_after":800,"derivative":{"exercise_price":8.25,"exercise_date":"2020-12-21","expiration_date":"2024-06-21","underlying":"Common Stock","underlying_shares":800},"source":{"system":"sec-edgar","filing":"0001209191-20-064953","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1178253/000120919120064953/doc4.xml","form_type":"4"}},{"id":2933299,"issuer":{"id":7194,"kind":"organization","name":"SCYNEXIS INC","symbol":"SCYX"},"owners":[{"id":54378,"kind":"person","name":"Angulo Gonzalez David","position":1,"cik":"0001644071","reported_name":"Angulo Gonzalez David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock Warrant","published_at":"2020-12-23T14:00:47.000Z","date":"2020-12-21","kind":"grant","acquired":true,"shares":800,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reflects the purchase on December 21, 2020 of 1,600 shares of the issuer's common stock, par value $0.001 per share, at a public offering price of $6.25 per share of common stock and accompanying warrants to purchase 0.50 of a share of common stock (Series 1 warrant) and 0.50 of a share of common stock (Series 2 warrant)."}],"balance_after":800,"derivative":{"exercise_price":7.33,"exercise_date":"2020-12-21","expiration_date":"2021-12-21","underlying":"Common Stock","underlying_shares":800},"source":{"system":"sec-edgar","filing":"0001209191-20-064953","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1178253/000120919120064953/doc4.xml","form_type":"4"}},{"id":2933298,"issuer":{"id":7194,"kind":"organization","name":"SCYNEXIS INC","symbol":"SCYX"},"owners":[{"id":54378,"kind":"person","name":"Angulo Gonzalez David","position":1,"cik":"0001644071","reported_name":"Angulo Gonzalez David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2020-12-23T14:00:47.000Z","date":"2020-12-21","kind":"purchase","acquired":true,"shares":1600,"price":6.25,"value":10000.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reflects the purchase on December 21, 2020 of 1,600 shares of the issuer's common stock, par value $0.001 per share, at a public offering price of $6.25 per share of common stock and accompanying warrants to purchase 0.50 of a share of common stock (Series 1 warrant) and 0.50 of a share of common stock (Series 2 warrant)."}],"balance_after":23780,"source":{"system":"sec-edgar","filing":"0001209191-20-064953","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1178253/000120919120064953/doc4.xml","form_type":"4"}},{"id":2956759,"issuer":{"id":7194,"kind":"organization","name":"SCYNEXIS INC","symbol":"SCYX"},"owners":[{"id":54378,"kind":"person","name":"Angulo Gonzalez David","position":1,"cik":"0001644071","reported_name":"Angulo Gonzalez David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2020-12-05T01:57:36.000Z","date":"2020-11-25","kind":"tax_withholding","acquired":false,"shares":4323,"price":6.81,"value":29439.63,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares withheld by and surrendered to the Issuer to satisfy tax withholding obligations that arose in connection with a vesting event from a restricted stock unit award."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 200 shares acquired in 2020 by the reporting person under the Issuer's 2014 Employee Stock Purchase Plan: 100 shares on March 5, 2020 and 100 shares on September 5, 2020."}],"balance_after":22180,"source":{"system":"sec-edgar","filing":"0001209191-20-061876","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1178253/000120919120061876/doc4.xml","form_type":"4"}},{"id":2956758,"issuer":{"id":7194,"kind":"organization","name":"SCYNEXIS INC","symbol":"SCYX"},"owners":[{"id":54378,"kind":"person","name":"Angulo Gonzalez David","position":1,"cik":"0001644071","reported_name":"Angulo Gonzalez David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2020-12-05T01:57:36.000Z","date":"2020-02-15","kind":"tax_withholding","acquired":false,"shares":1175,"price":9.8,"value":11515.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares withheld by and surrendered to the Issuer to satisfy tax withholding obligations that arose in connection with a vesting event from a restricted stock unit award."}],"balance_after":26303,"source":{"system":"sec-edgar","filing":"0001209191-20-061876","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1178253/000120919120061876/doc4.xml","form_type":"4"}},{"id":3292106,"issuer":{"id":7194,"kind":"organization","name":"SCYNEXIS INC","symbol":"SCYX"},"owners":[{"id":54378,"kind":"person","name":"Angulo Gonzalez David","position":1,"cik":"0001644071","reported_name":"Angulo Gonzalez David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-02-04T21:03:22.000Z","date":"2020-01-31","kind":"grant","acquired":true,"shares":450000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/48th of the shares subject to the option vest monthly for 48 months as measured from the date of grant."}],"balance_after":450000,"derivative":{"exercise_price":0.863,"expiration_date":"2030-01-30","underlying":"Common Stock","underlying_shares":450000},"source":{"system":"sec-edgar","filing":"0001209191-20-006269","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1178253/000120919120006269/doc4.xml","form_type":"4"}},{"id":3650227,"issuer":{"id":7194,"kind":"organization","name":"SCYNEXIS INC","symbol":"SCYX"},"owners":[{"id":54378,"kind":"person","name":"Angulo Gonzalez David","position":1,"cik":"0001644071","reported_name":"Angulo Gonzalez David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-02-19T21:51:11.000Z","date":"2019-02-15","kind":"grant","acquired":true,"shares":150000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"1/48th of the shares subject to the option vest monthly for 48 months as measured from the date of grant."}],"balance_after":150000,"derivative":{"exercise_price":1.38,"expiration_date":"2029-02-14","underlying":"Common Stock","underlying_shares":150000},"source":{"system":"sec-edgar","filing":"0001209191-19-011123","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1178253/000120919119011123/doc4.xml","form_type":"4"}},{"id":3650226,"issuer":{"id":7194,"kind":"organization","name":"SCYNEXIS INC","symbol":"SCYX"},"owners":[{"id":54378,"kind":"person","name":"Angulo Gonzalez David","position":1,"cik":"0001644071","reported_name":"Angulo Gonzalez David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2019-02-19T21:51:11.000Z","date":"2019-02-15","kind":"grant","acquired":true,"shares":150000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units that vest 25% per year over four years."}],"balance_after":271790,"source":{"system":"sec-edgar","filing":"0001209191-19-011123","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1178253/000120919119011123/doc4.xml","form_type":"4"}},{"id":3713554,"issuer":{"id":7194,"kind":"organization","name":"SCYNEXIS INC","symbol":"SCYX"},"owners":[{"id":54378,"kind":"person","name":"Angulo Gonzalez David","position":1,"cik":"0001644071","reported_name":"Angulo Gonzalez David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common stock","published_at":"2019-01-02T16:28:03.000Z","date":"2018-12-31","kind":"purchase","acquired":true,"shares":12000,"price":0.4959,"value":5950.8,"ownership":{"direct":true},"balance_after":121790,"source":{"system":"sec-edgar","filing":"0001209191-19-000037","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1178253/000120919119000037/doc4.xml","form_type":"4"}},{"id":3820644,"issuer":{"id":7194,"kind":"organization","name":"SCYNEXIS INC","symbol":"SCYX"},"owners":[{"id":54378,"kind":"person","name":"Angulo Gonzalez David","position":1,"cik":"0001644071","reported_name":"Angulo Gonzalez David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2018-09-10T13:09:07.000Z","date":"2018-09-06","kind":"purchase","acquired":true,"shares":7000,"price":1.27,"value":8890.0,"ownership":{"direct":true},"balance_after":108790,"source":{"system":"sec-edgar","filing":"0001209191-18-050184","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1178253/000120919118050184/doc4.xml","form_type":"4"}},{"id":3977025,"issuer":{"id":7194,"kind":"organization","name":"SCYNEXIS INC","symbol":"SCYX"},"owners":[{"id":54378,"kind":"person","name":"Angulo Gonzalez David","position":1,"cik":"0001644071","reported_name":"Angulo Gonzalez David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2018-04-02T12:10:11.000Z","date":"2018-03-29","kind":"purchase","acquired":true,"shares":6000,"price":1.36,"value":8160.0,"ownership":{"direct":true},"balance_after":101790,"source":{"system":"sec-edgar","filing":"0001209191-18-022265","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1178253/000120919118022265/doc4.xml","form_type":"4"}},{"id":4001230,"issuer":{"id":7194,"kind":"organization","name":"SCYNEXIS INC","symbol":"SCYX"},"owners":[{"id":54378,"kind":"person","name":"Angulo Gonzalez David","position":1,"cik":"0001644071","reported_name":"Angulo Gonzalez David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2018-03-12T20:43:29.000Z","date":"2018-03-08","kind":"purchase","acquired":true,"shares":7000,"price":1.39,"value":9730.0,"ownership":{"direct":true},"balance_after":95790,"source":{"system":"sec-edgar","filing":"0001209191-18-018877","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1178253/000120919118018877/doc4.xml","form_type":"4"}},{"id":4001217,"issuer":{"id":7194,"kind":"organization","name":"SCYNEXIS INC","symbol":"SCYX"},"owners":[{"id":54378,"kind":"person","name":"Angulo Gonzalez David","position":1,"cik":"0001644071","reported_name":"Angulo Gonzalez David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock Warrant (right to buy)","published_at":"2018-03-12T12:48:55.000Z","date":"2018-03-08","kind":"purchase","acquired":true,"shares":6655,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reflects the purchase on March 8, 2018, of 14,790 shares of the issuer's common stock, par value $0.001 per share, at a public offering price of $1.69 per share of common stock and accompanying warrants to purchase 0.75 of a share of common stock (Series 1 warrant) and 0.45 of a share of common stock (Series 2 warrant)."}],"balance_after":6655,"derivative":{"exercise_price":2,"exercise_date":"2018-03-08","expiration_date":"2023-03-08","underlying":"Common Stock","underlying_shares":6655},"source":{"system":"sec-edgar","filing":"0001209191-18-018705","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1178253/000120919118018705/doc4.xml","form_type":"4"}},{"id":4001216,"issuer":{"id":7194,"kind":"organization","name":"SCYNEXIS INC","symbol":"SCYX"},"owners":[{"id":54378,"kind":"person","name":"Angulo Gonzalez David","position":1,"cik":"0001644071","reported_name":"Angulo Gonzalez David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock Warrant (right to buy)","published_at":"2018-03-12T12:48:55.000Z","date":"2018-03-08","kind":"purchase","acquired":true,"shares":11092,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reflects the purchase on March 8, 2018, of 14,790 shares of the issuer's common stock, par value $0.001 per share, at a public offering price of $1.69 per share of common stock and accompanying warrants to purchase 0.75 of a share of common stock (Series 1 warrant) and 0.45 of a share of common stock (Series 2 warrant)."}],"balance_after":11092,"derivative":{"exercise_price":1.85,"exercise_date":"2018-03-08","expiration_date":"2019-03-14","underlying":"Common Stock","underlying_shares":11092},"source":{"system":"sec-edgar","filing":"0001209191-18-018705","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1178253/000120919118018705/doc4.xml","form_type":"4"}},{"id":4001215,"issuer":{"id":7194,"kind":"organization","name":"SCYNEXIS INC","symbol":"SCYX"},"owners":[{"id":54378,"kind":"person","name":"Angulo Gonzalez David","position":1,"cik":"0001644071","reported_name":"Angulo Gonzalez David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2018-03-12T12:48:55.000Z","date":"2018-03-08","kind":"purchase","acquired":true,"shares":14790,"price":1.69,"value":24995.1,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reflects the purchase on March 8, 2018, of 14,790 shares of the issuer's common stock, par value $0.001 per share, at a public offering price of $1.69 per share of common stock and accompanying warrants to purchase 0.75 of a share of common stock (Series 1 warrant) and 0.45 of a share of common stock (Series 2 warrant)."}],"balance_after":88790,"source":{"system":"sec-edgar","filing":"0001209191-18-018705","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1178253/000120919118018705/doc4.xml","form_type":"4"}},{"id":4063074,"issuer":{"id":7194,"kind":"organization","name":"SCYNEXIS INC","symbol":"SCYX"},"owners":[{"id":54378,"kind":"person","name":"Angulo Gonzalez David","position":1,"cik":"0001644071","reported_name":"Angulo Gonzalez David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock option (right to buy)","published_at":"2018-02-13T22:06:14.000Z","date":"2018-02-09","kind":"grant","acquired":true,"shares":200000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/48th of the shares subject to the option vest monthly for 48 months as measured from the date of grant."}],"balance_after":200000,"derivative":{"exercise_price":1.69,"expiration_date":"2028-02-08","underlying":"Common Stock","underlying_shares":200000},"source":{"system":"sec-edgar","filing":"0001209191-18-009636","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1178253/000120919118009636/doc4.xml","form_type":"4"}},{"id":4235435,"issuer":{"id":7194,"kind":"organization","name":"SCYNEXIS INC","symbol":"SCYX"},"owners":[{"id":54378,"kind":"person","name":"Angulo Gonzalez David","position":1,"cik":"0001644071","reported_name":"Angulo Gonzalez David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2017-08-14T20:29:09.000Z","date":"2017-08-11","kind":"purchase","acquired":true,"shares":10000,"price":1.55,"value":15500.0,"ownership":{"direct":true},"balance_after":72000,"source":{"system":"sec-edgar","filing":"0001178253-17-000017","document":"wf-form4_150274201826748.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1178253/000117825317000017/wf-form4_150274201826748.xml","form_type":"4"}},{"id":4321038,"issuer":{"id":7194,"kind":"organization","name":"SCYNEXIS INC","symbol":"SCYX"},"owners":[{"id":54378,"kind":"person","name":"Angulo Gonzalez David","position":1,"cik":"0001644071","reported_name":"Angulo Gonzalez David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2017-05-15T12:17:33.000Z","date":"2017-05-12","kind":"purchase","acquired":true,"shares":15000,"price":1.7,"value":25500.0,"ownership":{"direct":true},"balance_after":62000,"source":{"system":"sec-edgar","filing":"0001178253-17-000008","document":"wf-form4_149485063942281.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1178253/000117825317000008/wf-form4_149485063942281.xml","form_type":"4"}},{"id":4471276,"issuer":{"id":7194,"kind":"organization","name":"SCYNEXIS INC","symbol":"SCYX"},"owners":[{"id":54378,"kind":"person","name":"Angulo Gonzalez David","position":1,"cik":"0001644071","reported_name":"Angulo Gonzalez David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (right to buy)","published_at":"2017-02-02T19:23:15.000Z","date":"2017-01-31","kind":"grant","acquired":true,"shares":140000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"2.08% of the shares subject to the option vest monthly for 48 months as measured from the date of grant."}],"balance_after":140000,"derivative":{"exercise_price":3.02,"expiration_date":"2027-01-31","underlying":"Common Stock","underlying_shares":140000},"source":{"system":"sec-edgar","filing":"0001628280-17-000754","document":"wf-form4_148606338202189.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1178253/000162828017000754/wf-form4_148606338202189.xml","form_type":"4"}},{"id":4517159,"issuer":{"id":7194,"kind":"organization","name":"SCYNEXIS INC","symbol":"SCYX"},"owners":[{"id":54378,"kind":"person","name":"Angulo Gonzalez David","position":1,"cik":"0001644071","reported_name":"Angulo Gonzalez David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2016-12-19T11:44:04.000Z","date":"2016-12-16","kind":"purchase","acquired":true,"shares":4000,"price":3.25,"value":13000.0,"ownership":{"direct":true},"balance_after":46000,"source":{"system":"sec-edgar","filing":"0001628280-16-022084","document":"wf-form4_148214783049485.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1178253/000162828016022084/wf-form4_148214783049485.xml","form_type":"4"}}]}